Pliant Therapeutics, Inc. (PLRX) Misses Q1 EPS by 15c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q1 EPS of ($0.92), $0.15 worse than the analyst estimate of ($0.77).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• A.O. Smith executive chairman to retire, CEO to assume chairman role